Chapter title |
Importance of GOLD Guidelines for Chronic Obstructive Pulmonary Disease
|
---|---|
Chapter number | 44 |
Book title |
Advances in Experimental Medicine and Biology
|
Published in |
Advances in experimental medicine and biology, June 2017
|
DOI | 10.1007/5584_2017_44 |
Pubmed ID | |
Book ISBNs |
978-3-31-969544-0, 978-3-31-969545-7
|
Authors |
Sadlonova, J., Osinova, D., Rozborilova, E., Osina, O., Novakova, E., Sadlonova, V., J. Sadlonova, D. Osinova, E. Rozborilova, O. Osina, E. Novakova, V. Sadlonova |
Abstract |
In December 2011, a major revision of GOLD 2011 guidelines was published based on the evidence-based medicine. The goal of GOLD 2011 is to determine the severity of the disease, its impact on the patient's health, and the risk of future events; all of which eventually guide therapy. A combined COPD assessment according to GOLD 2011 considers the patient's level of symptoms, spirometry abnormalities, risk of exacerbation, and the presence of comorbidities. GOLD 2011 stratifies patients into four basic groups labeled A, B, C, and D. The aim of the present study was to assess the importance of updated GOLD guidelines for the diagnosis, treatment, and prevention of COPD. We found that the multicomponent 2011 guidelines offer a significant advantage over the previous mono-component COPD assessment according to GOLD 2006 in terms of disease control and therapy management, with patients enjoying better spirometry values and a higher arterial oxygen content considered the primary outcomes of interest. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 60% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 20 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 20% |
Student > Doctoral Student | 2 | 10% |
Student > Master | 2 | 10% |
Other | 1 | 5% |
Professor | 1 | 5% |
Other | 3 | 15% |
Unknown | 7 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 4 | 20% |
Nursing and Health Professions | 2 | 10% |
Agricultural and Biological Sciences | 1 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 5% |
Social Sciences | 1 | 5% |
Other | 1 | 5% |
Unknown | 10 | 50% |